
The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.
Andrew Walker is vice president, device development, Vectura.

The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.

Published: August 1st 2021 | Updated: